Evidence map›Paper›PMID 27514007›Full record

ArticleNMR in biomedicine2016

Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.

G S Payne, L M Harris, G S Cairns, C Messiou, N M deSouza, A Macdonald, F Saran, M O Leach

Open access · hybridAbstract readEvaluation StudyValidation Study
In one paragraph

Article in NMR in biomedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Spectral editing inNMR in biomedicine · 2021
    Article
  8. Article
  9. Article
  10. Targeting tumor-associated acidity in cancer immunotherapy.Cancer immunology, immunotherapy : CII · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

G S PayneMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK. gsp@icr.ac.uk.
L M HarrisMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
G S CairnsMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
C MessiouMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
N M deSouzaMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
A MacdonaldMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
F SaranMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
M O LeachMRI Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
Royal Marsden NHS Foundation Trust · GBRoyal Marsden Hospital · GB

Funding

Cancer Research UK 13149Cancer Research UK 16464Cancer Research UK C1060/A10334Cancer Research UK C1060/A16464Cancer Research UK C7270/A13149Department of HealthMedical Research Council G0701533
6 · The paper itself

Abstract

(1) H MRS measurements of lactate are often confounded by overlapping lipid signals. Double-quantum (DQ) filtering eliminates lipid signals and permits single-shot measurements, which avoid subtraction artefacts in moving tissues. This study evaluated a single-voxel-localized DQ filtering method qualitatively and quantitatively for measuring lactate concentrations in the presence of lipid, using high-grade brain tumours in which the results could be compared with standard acquisition as a reference. Paired standard acquisition and DQ-filtered (1) H MR spectra were acquired at 3T from patients receiving treatment for glioblastoma, using fLASER (localization by adiabatic selective refocusing using frequency offset corrected inversion pulses) single-voxel localization. Data were acquired from 2 × 2 × 2 cm(3) voxels, with a repetition time of 1 s and 128 averages (standard acquisition) or 256 averages (DQ-filtered acquisition), requiring 2.15 and 4.3 min respectively. Of 37 evaluated data pairs, 20 cases (54%) had measureable lactate (fitted Cramér-Rao lower bounds ≤ 20%) in either the DQ-filtered or the standard acquisition spectra. The measured DQ-filtered lactate signal was consistently downfield of lipid (1.33 ± 0.03 ppm vs 1.22 ± 0.08 ppm; p = 0.002), showing that it was not caused by lipid breakthrough, and that it matched the lactate signal seen in standard measurements (1.36 ± 0.02 ppm). In the absence of lipid, similar lactate concentrations were measured by the two methods (mean ratio DQ filtered/standard acquisition = 1.10 ± 0.21). In 7/20 cases with measurable lactate, signal was not measureable in the standard acquisition owing to lipid overlap but was quantified in the DQ-filtered acquisition. Conversely, lactate was undetected in seven DQ-filtered acquisitions but visible using the standard acquisition. In conclusion, the DQ filtering method has proven robust in eliminating lipid and permits uncontaminated measurement of lactate. This is important validation prior to use in tissues outside the brain, which contain large amounts of lipid and which are often susceptible to motion.

Indexed as

Signal Processing, Computer-AssistedAlgorithmsBiomarkers, TumorBrain NeoplasmsHumansLactic AcidMagnetic Resonance ImagingMolecular ImagingNeoplasm GradingProton Magnetic Resonance SpectroscopyReproducibility of ResultsSensitivity and SpecificityBiomarkers, TumorLactic Acidbraindouble-quantum filterglioblastomalactateMRSsingle voxel

Identifiers

PMID27514007
PMCPMC5042032
OpenAlexW2516553195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.